Recruiting AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms NCT05198960 Conditions Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +24 more Locations CHU d'Angers — Angers, France CH d'Annecy — Annecy, France CH d'Argenteuil — Argenteuil, France CH d'Avignon — Avignon, France View all 42 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms NCT06371573 Conditions Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more Locations Federico II University — Naples, Italy View Trial Details
Active, Not Recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT03862157 Conditions Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blood Coagulation Disorders, +43 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
